⌘K

Login Start Free

Home/Filings/4/0001415889-25-010290

4//SEC Filing

Seehra Jasbir 4

Accession 0001415889-25-010290

CIK 0001664710other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:15 PM ET

Size

6.8 KB

Accession

0001415889-25-010290

Insider Transaction Report

Form 4

Period: 2025-04-04

Keros Therapeutics, Inc.KROS

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Exercise/Conversion
Common Stock
2025-04-04$0.30/sh+49,367$14,810→ 302,223 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-04-04−49,367→ 252,444 total
Exercise: $0.30Exp: 2028-03-25→ Common Stock (49,367 underlying)

Footnotes (1)

[F1]Immediately exercisable.

Documents

1 file

4
form4-04072025_040401.xmlPrimary

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1

filerCIK 0001732369

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 4:15 PM ET
Size: 6.8 KB

View on SEC.gov